Phase II study to assess SEG101 in Sickle Cell Patients
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
February 23, 2018
End Date
February 21, 2023
Administered By
Medicine, Hematology
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
February 23, 2018
End Date
February 21, 2023